Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David V Hansen

Showing results (31-40 of 40) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 40 results.
Cell Reports|January 19, 2018
Diverse Brain Myeloid Expression Profiles Reveal Distinct Microglial Activation States and Aspects of Alzheimer's Disease Not Evident in Mouse ModelsBrad A Friedman, Karpagam Srinivasan, Gai Ayalon, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|January 26, 2020
Trem2 Deletion Reduces Late-Stage Amyloid Plaque Accumulation, Elevates the Aβ42:Aβ40 Ratio, and Exacerbates Axonal Dystrophy and Dendritic Spine Loss in the PS2APP Alzheimer's Mouse ModelWilliam J Meilandt, Hai Ngu, Alvin Gogineni, et al.
Neuron|March 6, 2021
Trem2 restrains the enhancement of tau accumulation and neurodegeneration by β-amyloid pathologySeung-Hye Lee, William J Meilandt, Luke Xie, et al.
Cell Reports|August 22, 2019
Complement C3 Is Activated in Human AD Brain and Is Required for Neurodegeneration in Mouse Models of Amyloidosis and TauopathyTiffany Wu, Borislav Dejanovic, Vineela D Gandham, et al.
Cell Reports|August 1, 2016
Antibody-Mediated Targeting of Tau In Vivo Does Not Require Effector Function and Microglial EngagementSeung-Hye Lee, Claire E Le Pichon, Oskar Adolfsson, et al.
Journal of Alzheimer'S Disease : JAD|January 21, 2017
A Common Variant of IL-6R is Associated with Elevated IL-6 Pathway Activity in Alzheimer's Disease BrainsPatrick C G Haddick, Jessica L Larson, Nisha Rathore, et al.
Cell|February 5, 2013
A high-resolution enhancer atlas of the developing telencephalonAxel Visel, Leila Taher, Hani Girgis, et al.
Nature Medicine|November 25, 2014
A rare mutation in UNC5C predisposes to late-onset Alzheimer's disease and increases neuronal cell deathMonica K Wetzel-Smith, Julie Hunkapiller, Tushar R Bhangale, et al.
Neuron|March 27, 2026
Microglia-mediated protection against Alzheimer's disease pathology and detrimental effects in white matter revealed by Ptpn6 deletionAinhoa Etxeberria, Seung-Hye Lee, Julia A Kuhn, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|June 3, 2024
Neutral or Detrimental Effects of TREM2 Agonist Antibodies in Preclinical Models of Alzheimer's Disease and Multiple SclerosisAinhoa Etxeberria, Yun-An A Shen, Stephen Vito, et al.
Pageof 4

Showing results (31-40 of 40) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 40 results.
Cell Reports|January 19, 2018
Diverse Brain Myeloid Expression Profiles Reveal Distinct Microglial Activation States and Aspects of Alzheimer's Disease Not Evident in Mouse ModelsBrad A Friedman, Karpagam Srinivasan, Gai Ayalon, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|January 26, 2020
Trem2 Deletion Reduces Late-Stage Amyloid Plaque Accumulation, Elevates the Aβ42:Aβ40 Ratio, and Exacerbates Axonal Dystrophy and Dendritic Spine Loss in the PS2APP Alzheimer's Mouse ModelWilliam J Meilandt, Hai Ngu, Alvin Gogineni, et al.
Neuron|March 6, 2021
Trem2 restrains the enhancement of tau accumulation and neurodegeneration by β-amyloid pathologySeung-Hye Lee, William J Meilandt, Luke Xie, et al.
Cell Reports|August 22, 2019
Complement C3 Is Activated in Human AD Brain and Is Required for Neurodegeneration in Mouse Models of Amyloidosis and TauopathyTiffany Wu, Borislav Dejanovic, Vineela D Gandham, et al.
Cell Reports|August 1, 2016
Antibody-Mediated Targeting of Tau In Vivo Does Not Require Effector Function and Microglial EngagementSeung-Hye Lee, Claire E Le Pichon, Oskar Adolfsson, et al.
Journal of Alzheimer'S Disease : JAD|January 21, 2017
A Common Variant of IL-6R is Associated with Elevated IL-6 Pathway Activity in Alzheimer's Disease BrainsPatrick C G Haddick, Jessica L Larson, Nisha Rathore, et al.
Cell|February 5, 2013
A high-resolution enhancer atlas of the developing telencephalonAxel Visel, Leila Taher, Hani Girgis, et al.
Nature Medicine|November 25, 2014
A rare mutation in UNC5C predisposes to late-onset Alzheimer's disease and increases neuronal cell deathMonica K Wetzel-Smith, Julie Hunkapiller, Tushar R Bhangale, et al.
Neuron|March 27, 2026
Microglia-mediated protection against Alzheimer's disease pathology and detrimental effects in white matter revealed by Ptpn6 deletionAinhoa Etxeberria, Seung-Hye Lee, Julia A Kuhn, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|June 3, 2024
Neutral or Detrimental Effects of TREM2 Agonist Antibodies in Preclinical Models of Alzheimer's Disease and Multiple SclerosisAinhoa Etxeberria, Yun-An A Shen, Stephen Vito, et al.
Pageof 4